Incidence of Respiratory Viruses in Peruvian Children With Acute Respiratory Infections
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsDel Valle Mendoza, Juana
Cornejo Tapia, Ángela
Nazario Fuertes, Ronald
del Valle, Luis J.
Pumarola, Toma´ s
Acute respiratory infections
Respiratory syncytial viruses
MetadataShow full item record
CitationJuana del Valle Mendoza; Angela Cornejo-Tapia; Pablo Weilg; Eduardo Verne; Ronald Nazario-Fuertes; Claudia Ugarte; Luis J. del Valle; Toma´ s Pumarola. Incidence of Respiratory Viruses in Peruvian Children With Acute Respiratory Infections. J Med Virol [Internet]. 2015;1–8. Available from: http://hdl.handle.net/10757/347016
PublisherJohn Wiley & Sons
JournalJournal Medical Virology (J. Med. Virol)
AbstractAcute respiratory infections are responsible for high morbi–mortality in Peruvian children. However, the etiological agents are poorly identified. This study, conducted during the pandemic outbreak of H1N1 influenza in 2009, aims to determine the main etiological agents responsible for acute respiratory infections in children from Lima, Peru. Nasopharyngeal swabs collected from 717 children with acute respiratory infections between January 2009 and December 2010 were analyzed by multiplex RT-PCR for 13 respiratory viruses: influenza A, B, and C virus; parainfluenza virus (PIV) 1, 2, 3, and 4; and human respiratory syncytial virus (RSV) A and B, among others. Samples were also tested with direct fluorescent-antibodies (DFA) for six respiratory viruses. RT-PCR and DFA detected respiratory viruses in 240 (33.5%) and 85 (11.9%) cases, respectively. The most common etiological agents were RSV-A (15.3%), followed by influenza A (4.6%), PIV-1 (3.6%), and PIV-2 (1.8%). The viruses identified by DFA corresponded to RSV (5.9%) and influenza A (1.8%). Therefore, respiratory syncytial viruses (RSV) were found to be the most common etiology of acute respiratory infections. The authors suggest that active surveillance be conducted to identify the causative agents and improve clinical management, especially in the context of possible circulation of pandemic viruses
Showing items related by title, author, creator and subject.
Molecular etiological profile of atypical bacterial pathogens, viruses and coinfections among infants and children with community acquired pneumonia admitted to a national hospital in Lima, Perudel Valle-Mendoza, Juana; Silva-Caso, Wilmer; Cornejo-Tapia, Angela; Orellana-Peralta, Fiorella; Verne, Eduardo; Ugarte, Claudia; Aguilar-Luis, Miguel Angel; De Lama-Odría, María del Carmen; Nazario-Fuertes, Ronald; Esquivel-Vizcarra, Mónica; Casabona-Ore, Verónica; Weilg, Pablo; del Valle, Luis J. (2017-12-06)Objective: The main objective of this study was to detect the presence of 14 respiratory viruses and atypical bacteria (Mycoplasma pneumoniae, Chlamydia pneumoniae), via polymerase chain reaction in patients under 18 years old hospitalized due to community-acquired pneumonia (CAP) from Lima, Peru. Results: Atypical pathogens were detected in 40% (58/146); viral etiologies in 36% (52/146) and coinfections in 19% (27/146). The most common etiological agent was M. pneumoniae (n = 47), followed by C. pneumoniae (n = 11). The most frequent respiratory viruses detected were: respiratory syncytial virus A (n = 35), influenza virus C (n = 21) and parainfluenza virus (n = 10). Viral-bacterial and bacterium-bacterium coinfections were found in 27 cases. In our study population, atypical bacteria (40%) were detected as frequently as respiratory viruses (36%). The presence of M. pneumoniae and C. pneumoniae should not be underestimated as they can be commonly isolated in Peruvian children with CAP.Acceso abierto
Prevalence of Diabetes Mellitus and Its Associated Unfavorable Outcomes in Patients With Acute Respiratory Syndromes Due to Coronaviruses Infection: A Systematic Review and Meta-AnalysisPinedo-Torres, Isabel; Flores-Fernández, Magaly; Yovera-Aldana, Marlon; Gutierrez-Ortiz, Claudia; Zegarra-Lizana, Paolo; Intimayta-Escalante, Claudio; Moran-Mariños, Cristian; Alva-Diaz, Carlos; Pacheco-Barrios, Kevin (SAGE Publications Ltd, 2020-01-01)Introduction: Only 3 types of coronavirus cause aggressive respiratory disease in humans (MERS-Cov, SARS-Cov-1, and SARS-Cov-2). It has been reported higher infection rates and severe manifestations (ICU admission, need for mechanical ventilation, and death) in patients with comorbidities such as diabetes mellitus (DM). For this reason, this study aimed to determine the prevalence of diabetes comorbidity and its associated unfavorable health outcomes in patients with acute respiratory syndromes for coronavirus disease according to virus types. Methods: Systematic review of literature in Pubmed/Medline, Scopus, Web of Science, Cochrane, and Scielo until April of 2020. We included cohort and cross-sectional studies with no restriction by language or geographical zone. The selection and extraction were undertaken by 2 reviewers, independently. The study quality was evaluated with Loney’s instrument and data were synthesized by random effects model meta-analysis. The heterogeneity was quantified using an I2 statistic. Funnel plot, Egger, and Begg tests were used to evaluate publication biases, and subgroups and sensitivity analyses were performed. Finally, we used the GRADE approach to assess the evidence certainty (PROSPERO: CRD42020178049). Results: We conducted the pooled analysis of 28 studies (n = 5960). The prevalence analysis according to virus type were 451.9 diabetes cases per 1000 infected patients (95% CI: 356.74-548.78; I2 = 89.71%) in MERS-Cov; 90.38 per 1000 (95% CI: 67.17-118.38) in SARS-Cov-1; and 100.42 per 1000 (95% CI: 77.85, 125.26 I2 = 67.94%) in SARS-Cov-2. The mortality rate were 36%, 6%, 10% and for MERS-Cov, SARS-Cov-1, and SARS-Cov-2, respectively. Due to the high risk of bias (75% of studies had very low quality), high heterogeneity (I2 higher than 60%), and publication bias (for MERS-Cov studies), we down rate the certainty to very low. Conclusion: The prevalence of DM in patients with acute respiratory syndrome due to coronaviruses is high, predominantly with MERS-Cov infection. The unfavorable health outcomes are frequent in this subset of patients. Well-powered and population-based studies are needed, including detailed DM clinical profile (such as glycemic control, DM complications, and treatment regimens), comorbidities, and SARS-Cov-2 evolution to reevaluate the worldwide prevalence of this comorbidity and to typify clinical phenotypes with differential risk within the subpopulation of DM patients.Acceso abierto
About «Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: Results of a hospital survey of patients infected with human immunodeficiency virus, 2002-2012»Guillermo Ladera, Dayana Sianny; Ventocilla Gonzales, Iris Janet; firstname.lastname@example.org (Elsevier B.V., 2016-04)Cartas al editorAcceso abierto